Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Healthy aging

Public Health Today

Public Health Today—June 26, 2026

This weekly public health update highlights key developments across disease…

Public_Health

Public Health Weekly News - September 26th 2025

Public Health Update: Huntington’s Gene Therapy, Low-Cost HIV PrEP, New…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
LucidScope AI Audit Analyses
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Insilico Takeda AI Drug Discovery Deal | Lucid Diligence Brief
SERB–Hansa Idefirix Deal | Lucid Diligence Brief
Cell and Gene Therapy Today—July 2, 2026
Rare Diseases Today—July 2, 2026
Cardiovascular Today—July 2, 2026

Tags

AAVantgarde Bio Actair AI in neurology Alecensa ALK Fusion-Positive Solid Tumours American Cancer Society american medical association Avant Technologies beacon biosignals BEQALZI biomarin pharmaceutical Blood–brain barrier Boan Biotech CD8-Targeted LNP CTA313 dementia care Drug discovery AI EC Eosinophilic Chronic Obstructive Pulmonary Disease ESC Digital & AI Summit ESR1 European Union glycochemistry homozygous familial hypercholesterolaemia IsoDDE lunit measurable residual disease nizubaglustat Nurix OCT imaging Ohio State University pediatric AD provider MSO Pulmonary vascular disease QIMR Berghofer Quotient Therapeutics Simcere Pharmaceutical SkinVision Sophia Genetics Targeted Intra-Arterial Drug Delivery Tarlatamab tenaya therapeutics tulisokibart Upstream Bio VAX-A1

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Insilico Takeda AI Drug Discovery Deal | Lucid Diligence Brief
SERB–Hansa Idefirix Deal | Lucid Diligence Brief
Cell and Gene Therapy Today—July 2, 2026
Rare Diseases Today—July 2, 2026
Cardiovascular Today—July 2, 2026

TAGS

AAVantgarde Bio Actair AI in neurology Alecensa ALK Fusion-Positive Solid Tumours American Cancer Society american medical association Avant Technologies beacon biosignals BEQALZI biomarin pharmaceutical Blood–brain barrier Boan Biotech CD8-Targeted LNP CTA313 dementia care Drug discovery AI EC Eosinophilic Chronic Obstructive Pulmonary Disease ESC Digital & AI Summit ESR1 European Union glycochemistry homozygous familial hypercholesterolaemia IsoDDE lunit measurable residual disease nizubaglustat Nurix OCT imaging Ohio State University pediatric AD provider MSO Pulmonary vascular disease QIMR Berghofer Quotient Therapeutics Simcere Pharmaceutical SkinVision Sophia Genetics Targeted Intra-Arterial Drug Delivery Tarlatamab tenaya therapeutics tulisokibart Upstream Bio VAX-A1

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy